Caricamento...
Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
This study was designed to verify the in vivo efficacy of sulfoxide and sulfone fexinidazole metabolites following oral administration in a murine model of Chagas disease. Female Swiss mice infected with the Y strain of Trypanosoma cruzi were treated orally once per day with each metabolite at doses...
Salvato in:
| Natura: | Articolo |
|---|---|
| Lingua: | en |
| Pubblicazione: |
American Society for Microbiology
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4136024/ https://ncbi.nlm.nih.gov/pubmed/24841257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02754-13 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|